Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy

Cell Transplantation

Volumn 17, Issue 8, 2008, Pages 955-968

  Bilic, Grozdana ^a   Zeisberger, Steffen M ^a   Mallik, Ajit S ^a,b   Zimmermann, Roland ^a   Zisch, Andreas H ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cell transplantation; Culture; Human amnion epithelial cells; Human amnion mesenchymal cells; Sternness markers

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CELL MARKER; ENDOGLIN; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; STEM CELL FACTOR; TELOMERASE REVERSE TRANSCRIPTASE; THY 1 ANTIGEN; BIOLOGICAL MARKER; MEMBRANE ANTIGEN; MESSENGER RNA;

AMNION CELL; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL STRUCTURE; CELL TYPE; CLONOGENESIS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MESENCHYME CELL; PHENOTYPE; PLACENTA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL EXPANSION; STROMA CELL; AMNION; BIOLOGICAL THERAPY; CELL CULTURE; CELL SHAPE; CELL SURVIVAL; COMPARATIVE STUDY; CULTURE TECHNIQUE; CYTOLOGY; EPITHELIUM CELL; GENETICS; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; METHODOLOGY; PHYSIOLOGY; TRANSPLANTATION;

AMNION; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELL FACTOR; STROMAL CELLS; TISSUE THERAPY;

EID: 58149387272     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368908786576507     Document Type: Article

References (31)

1. Alviano, F.; Fossati, V.; Marchionni, C.; Arpinati, M.; Bonsi, L.; Franchina, M.; Lanzoni, G.; Cantoni, S.; Cavallini, C.; Bianchi, F.; Tazzari, P. L.; Pasquinelli, G.; Foroni, L.; Ventura, C.; Grossi, A.; Bagnara, G. P. Term Amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev. Biol. 7:11; 2007.
2. Bailo, M.; Soncini, M.; Vertua, E.; Signoroni, P. B.; Sanzone, S.; Lombardi, G.; Arienti, D.; Calamani, F.; Zatti, D.; Paul, P.; Albertini, A.; Zorzi, F.; Cavagnini, A.; Candotti, F.; Wengler, G. S.; Parolini, O. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78(10): 1439-1448; 2004.
3. Bilic, G.; Hall, H.; Bittermann, A. G.; Zammeretti, P.; Burkhart, T.; Ochsenbein-Kolble, N.; Zimmermann, R. Human preterm amnion cells cultured in 3-dimensional collagen I and fibrin matrices for tissue engineering purposes. Am. J. Obstet. Gynecol. 193(5): 1724-1732; 2005.
4. Bilic, G.; Ochsenbein-Kolble, N.; Hall, H.; Huch, R.; Zimmermann, R. In vitro lesion repair by human amnionepithelial and mesenchymal cells. Am. J. Obstet. Gynecol. 190(l):87-92; 2004.
5. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315-317; 2006.
6. Freshney, R. I. Primary culture. In: Freshney, R. I., ed. Culture of animal cells, 5th ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2005:175-197.
7. Fuchs, E.; Segre, J. A. Stem cells: A new lease on life. Cell 100(1):143-155; 2000.
8. Hodges, H.; Pollock, K.; Stroemer, P.; Patel, S.; Stevanato, L.; Reuter, I.; Sinden, J. Making stem cell lines suitable for transplantation. Cell Transplant. 16(2):101-115; 2007.
9. In't Anker, P. S.; Scherjon, S. A.; Kleijburg-van der Keur, C.; de Groot-Swings, G. M.; Claas, F. H.; Fibbe, W. E.; Kanhai, H. H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22(7): 1338-1345; 2004.
10. Keating, A. Mesenchymal stromal cells. Curr. Opin. Hem-atol. 13(6):419-425; 2006.
11. Kobayashi, N. Cell therapy for diabetes mellitus. Cell Transplant. 15(10):849-854; 2006.
12. Malak, T. M.; Bell, S. C. Structural characteristics of term human fetal membranes: A novel zone of extreme morphological alteration within the rupture site. Br. J. Obstet. Gynaecol. 101(5):375-386; 1994.
13. McLaren, J.; Malak, T. M.; Bell, S. C. Structural characteristics of term human fetal membranes prior to labour: Identification of an area of altered morphology overlying the cervix. Hum. Reprod. 14(1):237-241; 1999.
14. Miki, T.; Lehmann, T.; Cai, H.; Stolz, D. B.; Strom, S. C. Stem cell characteristics of amniotic epithelial cells. Stem Cells 23(10):1549-1559; 2005.
15. Miki, T.; Mitamura, K.; Ross, M. A.; Stolz, D. B.; Strom, S. C. Identification of stem cell marker-positive cells by immunofluorescence in term human amnion. J. Reprod. Immunol. 75(2):91-96; 2007.
16. Miki, T.; Strom, S. C. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev. 2(2):133-142; 2006.
17. Niwa, H.; Masui, S.; Chambers, I.; Smith, A. G.; Miyazaki, J. Phenotypic complementation establishes requirements for specific POU domain and generic transactiva-tion function of Oct-3/4 in embryonic stem cells. Mol. Cell. Biol. 22(5):1526-1536; 2002.
18. Noguchi, H.; Xu, G.; Matsumoto, S.; Kaneto, H.; Kobayashi, N.; Bonner-Weir, S.; Hayashi, S. Induction of pancreatic stem/progenitor cells into insulin-producing cells by adenoviral-mediated gene transfer technology. Cell Transplant. 15(10):929-938; 2006.
19. Ochsenbein-Kolble, N.; Bilic, G.; Hall, H.; Huch, R.; Zimmermann, R. Inducing proliferation of human amnion epithelial and mesenchymal cells for prospective engineering of membrane repair. J. Perinat. Med. 31(4):287-294; 2003.
20. Parry, S.; Strauss, 3rd, J. F. Premature rupture of the fetal membranes. N. Engl. J. Med. 338(10):663-670; 1998.
21. Pasquinelli, G.; Tazzari, P.; Ricci, F.; Vaselli, C.; Buzzi, M.; Conte, R.; Orrico, C.; Foroni, L.; Stella, A.; Alviano, F.; Bagnara, G. P.; Lucarelli, E. Ultrastructural characteristics of human mesenchymal stromal (stem) cells derivedfrom bone marrow and term placenta. Ultrastract. Pathol. 31(1):23-31; 2007.
22. Portmann-Lanz, C. B.; Schoeberlein, A.; Huber, A.; Sager, R.; Malek, A.; Holzgreve, W.; Surbek, D. V. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am. J. Obstet. Gynecol. 194(3):664-673; 2006.
23. Sakuragawa, N.; Kakinuma, K.; Kikuchi, A.; Okano, H.; Uchida, S.; Kamo, I.; Kobayashi, M.; Yokoyama, Y. Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J. Neurosci. Res. 78(2):208-214; 2004.
24. Stenn, K. S.; Link, R.; Moellmann, G.; Madri, J.; Kuklinska, E. Dispase, a neutral protease from Bacillus polymyxa, is a powerful fibronectinase and type IV collagenase. J. Invest. Dermatol. 93(2):287-290; 1989.
25. Stute, N.; Holtz, K.; Bubenheim, M.; Lange, C.; Blake, F.; Zander, A. R. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp. Hematol. 32(12): 1212-1225; 2004.
26. Takahashi, K.; Igura, K.; Zhang, X.; Mitsuru, A.; Takahashi, T. A. Effects of osteogenic induction on mesenchymal cells from fetal and maternal parts of human placenta. Cell Transplant. 13(4):337-341; 2004.
27. Takahashi, S.; Ohsugi, K.; Yamamoto, T.; Shiomi, M.; Sakuragawa, N. A novel approach to ex vivo gene therapy for familial hypercholesterolemia using human amniotic epithelial cells as a transgene carrier. Tohoku J. Exp. Med. 193 (4): 279-292; 2001.
28. Takashima, S.; Ise, H.; Zhao, P.; Akaike, T.; Nikaido, T. Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct. Funct. 29(3):73-84; 2004.
29. Wei, J. P.; Zhang, T. S.; Kawa, S.; Aizawa, T.; Ota, M.; Akaike, T.; Kato, K.; Konishi, I.; Nikaido, T. Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant. 12(5):545-552; 2003.
30. Wolbank, S.; Peterbauer, A.; Fahrner, M.; Hennerbichler, S.; van Griensven, M.; Stadler, G.; Redl, H.; Gabriel, C. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 13(6):1173-1183; 2007.
31. Zhao, P.; Ise, H.; Hongo, M.; Ota, M.; Konishi, I.; Nikaido, T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 79(5):528-535; 2005.